APP and Alzheimer disease: In AD, an altered cleavage of Amyloid precursor protein (APP), a type 1 integral membrane glycoprotein expressed in the brain, manipulated by Presenilins (PS)/γ-secretase leads to formation of insoluble amyloid-β (Aβ40–42) that deposit as pathological plaques in brain [147].